Thursday, April 23, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home AI & Quantum Computing

Rigetti Computing Shares Face Pivotal Earnings Test

SiterGedge by SiterGedge
March 4, 2026
in AI & Quantum Computing, Earnings, Tech & Software
0
Rigetti Stock
0
SHARES
16
VIEWS
Share on FacebookShare on Twitter

All eyes are on Rigetti Computing as the quantum computing specialist prepares to release its fourth-quarter and full-year 2025 financial results after today’s market close. While expectations remain modest, recent positive momentum from competitor IonQ has injected a degree of cautious optimism into the sector. Investors are keenly focused on the company’s hardware delivery timeline and the potential for securing larger commercial contracts.

Sector Momentum and Stock Performance

The quantum computing sector recently received a boost from IonQ’s stronger-than-anticipated earnings report, providing a tailwind for related equities, including Rigetti. Despite this short-term lift, Rigetti’s stock remains under significant pressure. Since the start of the year, its shares have declined by more than 27 percent, currently trading around €14.60. This price stands far below its 52-week high of €48.36. The stock’s 30-day volatility, exceeding 100 percent, underscores the pervasive uncertainty characterizing this emerging industry.

Financial Forecasts and Hardware Delays

Market analysts project a fourth-quarter 2025 loss of $0.03 per share on revenue of $2.33 million. This would represent a modest year-over-year sales increase of 2.6 percent—a relatively slow pace for a field built on substantial long-term promises.

A central concern for tonight’s earnings call is the delayed deployment of the 108-qubit Cepheus-1-108Q system. Initially scheduled for late 2025, its launch has been pushed to the end of March 2026, a shift the company attributes to extended validation processes. This delay intensifies the scrutiny on Rigetti’s ability to meet its revised deadlines.

Should investors sell immediately? Or is it worth buying Rigetti?

However, a significant order from India’s Centre for Development of Advanced Computing offers a promising development. The $8.4 million contract for a 108-qubit system marks the first major deal for this architecture and could serve as a reference for future business with research institutions. The timing of when this revenue will be recognized remains unclear, and its clarification could materially impact the revenue consensus for 2026, which currently sits at $21.3 million.

Strategic Partnerships and Future Roadmap

Investors will also seek updates on Rigetti’s strategic initiatives and technical milestones. The company’s collaboration with NVIDIA on the NVQLink platform, aimed at integrating classical and quantum computing infrastructure, continues to progress. In contrast, Rigetti was eliminated from an early phase of DARPA’s Quantum Benchmarking Initiative.

The long-term hardware roadmap presents ambitious targets: a system exceeding 150 qubits by the end of 2026, followed by a 1,000-qubit machine by the end of 2027. A key question for management during the conference call will be whether these goals remain achievable, providing a crucial gauge of the company’s competitive trajectory in the rapidly evolving quantum landscape.

Ad

Rigetti Stock: Buy or Sell?! New Rigetti Analysis from April 23 delivers the answer:

The latest Rigetti figures speak for themselves: Urgent action needed for Rigetti investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 23.

Rigetti: Buy or sell? Read more here...

Tags: Rigetti
SiterGedge

SiterGedge

Related Posts

Ocugen Stock
Analysis

Ocugen’s Cash Clock Ticks as Three Gene Therapy Programs Converge on Q3

April 23, 2026
IBM Stock
AI & Quantum Computing

IBM’s $11.6 Billion Confluent Deal Closes as Earnings Beat Meets Stock Selloff

April 23, 2026
Realty Income Stock
Analysis

Realty Income’s Institutional Backing Collides With Analyst Caution Ahead of Q1 Numbers

April 23, 2026
Next Post
Abbott Laboratories Stock

Abbott Laboratories Secures Legal Victory in Data Privacy Case

Axsome Stock

Axsome Therapeutics Expands Commercial Ambitions Amid Key Regulatory Milestones

T-Mobile US Stock

T-Mobile US Doubles Down on Network and Customer Growth Initiatives

Recommended

Viking Therapeutics Stock

Viking Therapeutics Stock Surges on Acquisition Speculation

5 months ago
Consumer Portfolio Services Stock

Subprime Auto Lender CPSS Sees Sharp Single-Day Rally Amid Longer-Term Decline

7 months ago
Compass Therapeutics Stock

Compass Therapeutics: A Biotech Contender Navigates Clinical Progress and Setbacks

8 months ago
Quantum eMotion Stock

Quantum eMotion Pursues US Stock Exchange Listing

3 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Netflix Newmont Mining Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

IBM’s $11.6 Billion Confluent Deal Closes as Earnings Beat Meets Stock Selloff

Realty Income’s Institutional Backing Collides With Analyst Caution Ahead of Q1 Numbers

AMD’s $60 Billion Infrastructure Bet: From Chip Sales to AI Megaprojects

Strategy’s Bitcoin Crown Comes With a $14.5 Billion Paper Wound

Uranium Energy’s Strategic Bet on a Consolidating Nuclear Landscape

Netflix Bets Big on Live Sports as Co-Founder Exits Stage Left

Trending

Battalion Oil Stock
Commodities

Battalion Oil: A $375 Million Shelf Filing Threatens to Overwhelm Record Operational Gains

by Rodolfo Hanigan
April 23, 2026
0

The whiplash hitting Battalion Oil’s shareholders this week has been brutal. On Tuesday, the stock surged 39...

Airbus Stock

Airbus Delivers a Mixed Picture: Record Service Ambitions Meet a Q1 Delivery Slump

April 23, 2026
Ocugen Stock

Ocugen’s Cash Clock Ticks as Three Gene Therapy Programs Converge on Q3

April 23, 2026
IBM Stock

IBM’s $11.6 Billion Confluent Deal Closes as Earnings Beat Meets Stock Selloff

April 23, 2026
Realty Income Stock

Realty Income’s Institutional Backing Collides With Analyst Caution Ahead of Q1 Numbers

April 23, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Battalion Oil: A $375 Million Shelf Filing Threatens to Overwhelm Record Operational Gains
  • Airbus Delivers a Mixed Picture: Record Service Ambitions Meet a Q1 Delivery Slump
  • Ocugen’s Cash Clock Ticks as Three Gene Therapy Programs Converge on Q3

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com